Agonist Met antibodies define the signalling threshold required for a full mitogenic and invasive program of Kaposi’s Sarcoma cells
- 1 September 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 334 (4), 1172-1179
- https://doi.org/10.1016/j.bbrc.2005.07.020
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Preferential Binding of Grb2 or Phosphatidylinositol 3-Kinase to the Met Receptor Has Opposite Effects on HGF-Induced Myoblast ProliferationExperimental Cell Research, 2002
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesisOncogene, 2002
- A differentiation switch for genetically modified hepatocytesThe FASEB Journal, 2001
- Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesisOncogene, 1999
- Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel PathwayPublished by Elsevier BV ,1998
- Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.JCI Insight, 1997
- Phosphatidylinositol 3-Kinase Activity Is Required for Hepatocyte Growth Factor-induced Mitogenic Signals in Epithelial CellsJournal of Biological Chemistry, 1996
- Specific Uncoupling of GRB2 from the Met ReceptorJournal of Biological Chemistry, 1996
- Differential activation of the extracellular signal-regulated kinase, Jun Kinase and Janus Kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposiʼs sarcoma cellsAIDS, 1996